Network Pharmacology-Based identification of pharmacological mechanism of SQFZ injection in combination with Docetaxel on lung cancer

Docetaxel is the widely-used first-line therapy to treat lung cancer around the world. However, tumor progression and severe side effect occurred in some patients with docetaxel treatment. Most of the side effects were caused by immunocompromise, which limits the long-term use of docetaxel. Shenqi F...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Tan, Baochen, Zhu, Yue, Zhang, Cheng, Wang, Yali, Wu, Zongxi, Sun, Wantong, Zhang, Yang, Lu, Shouying, Du
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418214/
https://www.ncbi.nlm.nih.gov/pubmed/30872765
http://dx.doi.org/10.1038/s41598-019-40954-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418214/
https://www.ncbi.nlm.nih.gov/pubmed/30872765
http://dx.doi.org/10.1038/s41598-019-40954-3

Ejemplares similares